Literature DB >> 31656765

Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit?

Mauricio Burotto1, Alex Renner2.   

Abstract

Entities:  

Year:  2019        PMID: 31656765      PMCID: PMC6789373          DOI: 10.21037/atm.2019.07.67

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  6 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Authors:  Andrew T Lenis; Claire S Burton; Vishnukamal Golla; Aydin Pooli; Izak Faiena; David C Johnson; Amirali Salmasi; Alexandra Drakaki; Kiran Gollapudi; Jeremy Blumberg; Allan J Pantuck; Karim Chamie
Journal:  Urol Oncol       Date:  2019-03-28       Impact factor: 3.498

3.  Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.

Authors:  E Jason Abel; Philippe E Spiess; Vitaly Margulis; Viraj A Master; Michael Mann; Kamran Zargar-Shoshtari; Leonardo D Borregales; Wade J Sexton; Datta Patil; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  J Urol       Date:  2017-03-06       Impact factor: 7.450

4.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Authors:  G H Mickisch; A Garin; H van Poppel; L de Prijck; R Sylvester
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

6.  Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era.

Authors:  Simon L Conti; I-Chun Thomas; Judith C Hagedorn; Benjamin I Chung; Glenn M Chertow; Todd H Wagner; James D Brooks; Sandy Srinivas; John T Leppert
Journal:  Int J Cancer       Date:  2014-05-01       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.